Medicare Enrolled
Dr. Amit Tibb, MD
Pulmonary Disease · Bronx, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tibb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tibb?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tibb
Dr. Amit Tibb is a pulmonary disease specialist in Bronx, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tibb performed 4,317 Medicare services across 2,046 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tibb received a total of $6,044 from 31 pharmaceutical and/or device companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tibb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in NY
$6,044 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,317
Medicare services
Top 6% in NY for pulmonary disease
2,046
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,042 | $103 | $229 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
550 | $110 | $245 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
484 | $69 | $159 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
322 | $156 | $328 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
306 | $150 | $445 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
261 | $92 | $203 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
226 | $64 | $154 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
199 | $35 | $140 |
| Ultrasound scan of chest An imaging test that uses sound waves to create pictures of the structures inside the chest. |
154 | $51 | $185 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
152 | $16 | $40 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
141 | $72 | $190 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
112 | $182 | $600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $146 | $368 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
45 | $30 | $76 |
| New patient office visit, complex (60-74 min) | 44 | $191 | $464 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $79 | $170 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
33 | $75 | $82 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
32 | $34 | $50 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
30 | $10 | $70 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
29 | $7 | $134 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
20 | $16 | $34 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
19 | $158 | $369 |
| Chest fluid drainage with tube insertion using imaging guidance This procedure removes fluid from the chest cavity and places a tube to stay in place for ongoing drainage. Imaging guidance is used to help position the tube accurately. |
17 | $126 | $950 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
17 | $28 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,044
Total received (2018-2024)
Avg $863/year across 7 years
Top 26% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
383
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,860 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$184 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$958
2023
$1,077
2022
$1,167
2021
$995
2020
$485
2019
$646
2018
$715
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$295
AstraZeneca Pharmaceuticals LP
$263
Mylan Specialty L.P.
$91
Actelion Pharmaceuticals US, Inc.
$80
Amgen Inc.
$62
Masimo Corporation
$36
Mallinckrodt Hospital Products Inc.
$35
Inspire Medical Systems, Inc.
$34
Regeneron Healthcare Solutions, Inc.
$32
Insmed, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 67.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,769
GlaxoSmithKline, LLC.
$1,493
Mylan Specialty L.P.
$445
Actelion Pharmaceuticals US, Inc.
$309
Covis Pharma GmBH
$259
Genentech USA, Inc.
$251
Insmed, Inc.
$241
Boehringer Ingelheim Pharmaceuticals, Inc.
$235
Philips Electronics North America Corporation
$131
GENZYME CORPORATION
$117
Teva Pharmaceuticals USA, Inc.
$96
Mallinckrodt Hospital Products Inc.
$92
Amgen Inc.
$90
Regeneron Healthcare Solutions, Inc.
$75
Grifols USA, LLC
$66
Novartis Pharmaceuticals Corporation
$44
Sunovion Pharmaceuticals Inc.
$38
Masimo Corporation
$36
Inspire Medical Systems, Inc.
$34
PFIZER INC.
$30
Pulmonx Corporation
$28
Vertex Pharmaceuticals Incorporated
$25
Circassia Pharmaceuticals Inc
$24
Baxter Healthcare
$24
Jazz Pharmaceuticals Inc.
$15
VERTEX PHARMACEUTICALS INCORPORATED
$15
ABBVIE INC.
$15
Janssen Pharmaceuticals, Inc
$15
Esperion Therapeutics, Inc.
$14
BOSTON SCIENTIFIC CORPORATION
$11
United Therapeutics Corporation
$9
Top 3 companies account for 61.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ADVAIR · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AirDuo Digihaler · Arikayce · BREO · BREZTRI · CINQAIR · DUPIXENT · Dymista · ELIQUIS · Esbriet · FASENRA · GENERAL PULMONARY · Hillrom - Life 2000 Ventilation System · INSPIRE · LONHALA MAGNAIR · NEXLETOL · NIOX VERO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR - 13 · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QVAR · SET and rainbow SET · SHINGRIX · SPIRIVA · STIOLTO RESPIMAT · SYMBICORT · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
664
Per 100K population
46.8
County median income
$49,036
Nearest hospital
JACOBI MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tibb is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tibb experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Tibb performed 1,042 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tibb receive payments from pharmaceutical companies?
Yes. Dr. Tibb received a total of $6,044 from 31 companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tibb's costs compare to other pulmonary diseases in Bronx?
Dr. Tibb's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tibb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Bronx
Browse pulmonary diseases in Bronx ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology